ELICIO THERAPEUTICS ANNOUNCES LATE-BREAKING PHASE 2 AMPLIFY-7P DATA SELECTED FOR PROFFERED PAPER ORAL PRESENTATION AT ESMO CONGRESS 2026

Reuters · 1d ago

Please log in to view news